Stock 4587 PEPTIDREAM INC.
Add to a list
To use this feature you must be a member
Log inSign up

News PeptiDream Inc.

Equities

4587

JP3836750004

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-03 am EDT 		5-day change 1st Jan Change
2,453 JPY +5.39% Intraday chart for PeptiDream Inc. +3.70% +65.02%
Jun. 14 PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment MT
Jun. 04 National Cancer Center and PeptiDream Announces the First Dosing of Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PeptiDream : Corporate Overview（July 2024, English version)
PU
PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment
MT
NCC and PeptiDream Announce the First Dosing of 64Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma
BU
National Cancer Center and PeptiDream Announces the First Dosing of Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma
CI
Peptidream Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024
CI
Jefferies Adjusts PeptiDream’s Price Target to 1,900 Yen From 1,400 Yen, Keeps at Hold
MT
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
BU
Peptidream Announces Expansion of Peptide Discovery Collaboration with Novartis
CI
PeptiDream Inc. Announces Expansion of Peptide Discovery Collaboration with Novartis Pharma AG
CI
Certain Preferred Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.
CI
Certain Stock Options of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.
CI
Certain Common Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.
CI
PeptiDream to Partake in Bristol Myers' Tender Offer for All RayzeBio Shares
MT
PeptiDream Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024
CI
PeptiDream Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Jefferies Adjusts PeptiDream's Price Target to 1,400 Yen From 1,300 Yen, Keeps at Hold
MT
Linqmed Inc. announced that it has received ¥680 million in funding from a group of investors
CI
PeptiDream Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
PeptiDream : Corporate Presentation（November 2023, English version)(2MB)
PU
PeptiDream : コーポレート・プレゼンテーション(2023年11月、英語版）(2MB)
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4587 Stock
  4. News PeptiDream Inc.